Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin 40 mg vs 60 mg for venous thromboembolism prophylaxis in bariatric surgery
TCTR20201016001Phase 0Not yet recruiting
- Start
- Oct 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 0, randomised trial of enoxaparin in venous thromboembolism (VTE) (2 arms), sponsored by none. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on TCTR20201016001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201016001.